BackgroundThe opioid epidemic in the United States and the known risks of opioid utilization highlight the need for a better understanding of pain management around kidney transplantation. Although studies have been recently published describing efforts to minimize opioid therapy, clinical practices across the U.S. remain unknown.ObjectiveThe primary outcome of this study was to describe the programmatic use of opioids in the perioperative timeframe and upon discharge after kidney transplantation in the U.S.MethodsThis study was a cross‐sectional survey of transplant pharmacists to evaluate the national landscape of opioid management with regard to pretransplant candidacy, perioperative pain management, and posttransplant pain management. A 25‐question survey was distributed to members of transplant pharmacy listservs within the U.S. in March 2020.ResultsSixty‐three of 208 (30.3%) adult kidney transplant centers responded to the survey. The majority of institutions would actively list patients on an opioid (84.1%, 53/63) or medication for opioid use disorder (MOUD) (58.2%, 32/55). The majority of institutions (84%) utilized opioids for first‐line postoperative pain management in opioid‐naïve patients. More than half of the centers (55%) did not differentiate the postoperative pain regimen between opioid‐naïve and opioid‐experienced patients. A total of 72.6% of institutions prescribed opioids upon discharge from transplant, and 10.8% of the institutions prescribed subsequent opioid analgesics in the outpatient setting. Most (82.7%) of responders reported that their institutions did not have a written protocol or policy for posttransplant pain management.ConclusionThis survey highlights the existence of significant practice heterogeneity regarding opioid and MOUD utilization across kidney transplant programs in the U.S. Thus, transplant pharmacists have the opportunity within the context of their multidisciplinary team to develop multimodal pain management strategies to minimize opioid use while maintaining adequate pain control in kidney transplant candidates and recipients to continue to optimize patient care.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.